CEO, Vaxess Technologies
Michael Schrader is the CEO of Vaxess, a clinical-stage company bringing healthcare out of the clinic and into patients’ lives with the MIMIX patch platform. The company has a pipeline of vaccines and biologics under development, including the first influenza vaccine intended for home-based administration. He also serves as an Expert-In-Residence at the Harvard Office of Technology Development and as a Key Advisory Board Member for the Harvard Blavatnik Fellowship program. Prior to Vaxess, Michael spent time at Google and Honda where he helped bring a range of products to market and earned more than fifteen patents. Michael received his B.S. in Mechanical Engineering from Purdue University and his M.B.A. from Harvard.